ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,243, issued on Sept. 29, was assigned to Anovia Biosciences Inc. (New York).

"LOX enzyme inhibiting methods and compositions" was invented by Michael Clare (New York), Maria Kleppe (New York), Xiang Li (Beijing), Juan Du (Beijing) and Ronggang Liu (Berwyn, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to compounds, pharmaceutical compositions and their use for treating fibrotic disorders, proliferative disorders, cardiovascular diseases, acute and chronic inflammatory disorders, primary and metastatic cancer, pulmonary conditions, ocular diseases, or neurological and neuropsychiatric conditions. One particular aspect of ...